2020 annual financial data
Ovid Therapeutics 2020 Net margin
Direct answer
Net margin was -639.83%.
Operating income was -81,430,977 USD and net income was -80,728,728 USD.
Operating cash flow was -51,583,914 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,617,221 USD
- Operating income
- -81,430,977 USD
- Net income
- -80,728,728 USD
- Operating cash flow
- -51,583,914 USD